| CTRP13 Mitigates Endothelial Cell Ferroptosis via the AMPK/KLF4 Pathway: Implications for Atherosclerosis Protection. | CTRP13 Mitigates Endothelial Cell Ferroptosis via the AMPK/KLF4 Pathway: Implications for Atherosclerosis Protection.
Du J, Wu J, Zhang Y, Liu Q, Luo X, Huang X, Wang X, Yang F, Hou J., Free PMC Article | 02/7/2024 |
| CTRP13 alleviates palmitic acid-induced inflammation, oxidative stress, apoptosis and endothelial cell dysfunction in HUVECs. | CTRP13 alleviates palmitic acid-induced inflammation, oxidative stress, apoptosis and endothelial cell dysfunction in HUVECs.
Zhu W, Yang G, Chen N, Zhang W, Gao Q, Li T, Yuan N, Jin H. | 01/26/2024 |
| CTRP13 ablation improves systemic glucose and lipid metabolism. | CTRP13 ablation improves systemic glucose and lipid metabolism.
Chen F, Sarver DC, Saqib M, Zhou M, Aja S, Seldin MM, Wong GW., Free PMC Article | 11/30/2023 |
| Low Complement C1q/TNF-related Protein-13 Levels are Associated with Childhood Obesity But not Binge Eating Disorder | Low Complement C1q/TNF-related Protein-13 Levels are Associated with Childhood Obesity But not Binge Eating Disorder.
Erbaş İM, Paketçi A, Turan S, Şişman AR, Demir K, Böber E, Abacı A., Free PMC Article | 06/18/2022 |
| CTRP13 preserves endothelial function in diabetic mice by regulating GCH1/BH4 axis-dependent eNOS coupling, suggesting the therapeutic potential of CTRP13 against diabetic vasculopathy. | CTRP13 Preserves Endothelial Function by Targeting GTP Cyclohydrolase 1 in Diabetes.
Wang C, Chao Y, Xu W, Liang M, Deng S, Zhang D, Huang K. | 07/11/2020 |
| findings define CTRP13 as a novel approach for preventing atherosclerotic plaque formation via modulation of lipid uptake and foam-cell migration | CTRP13 inhibits atherosclerosis via autophagy-lysosome-dependent degradation of CD36.
Wang C, Xu W, Liang M, Huang D, Huang K. | 10/5/2019 |
| BAI3 mediates the inhibitory effects of C1ql3 on insulin secretion from pancreatic beta-cells. | Complement 1q-like-3 protein inhibits insulin secretion from pancreatic β-cells via the cell adhesion G protein-coupled receptor BAI3.
Gupta R, Nguyen DC, Schaid MD, Lei X, Balamurugan AN, Wong GW, Kim JA, Koltes JE, Kimple ME, Bhatnagar S., Free PMC Article | 06/29/2019 |
| Study results indicated that decreased adiponectin, CTRP12, and CTRP13 levels, regardless of obesity, could independently predict polycystic ovarian syndrome (PCOS). This finding suggested a novel link between adipokines and PCOS. | Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesity.
Shanaki M, Moradi N, Fadaei R, Zandieh Z, Shabani P, Vatannejad A., Free PMC Article | 06/8/2019 |
| CTRP13 is a novel adipokine that is down-regulated in the serum of type 2 diabetics. | The Circulating Levels of Complement-C1q/TNF-Related Protein 13 (CTRP13) in Patients with Type 2 Diabetes and its Association with Insulin Resistance.
Afrookhteh A, Emamgholipour S, Alipoor B, Moradi N, Meshkani R, Nasli-Esfahani E, Rahimipour A, Shanaki M. | 12/16/2017 |
| decreased levels of CTRP3 and especially CTRP13 were associated with increased risk of T2DM and CAD | Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus.
Fadaei R, Moradi N, Baratchian M, Aghajani H, Malek M, Fazaeli AA, Fallah S., Free PMC Article | 07/15/2017 |
| CTRP13 reduces glucose output in hepatocytes by inhibiting the mRNA expression of gluconeogenic enzymes, glucose-6-phosphatase and the cytosolic form of phosphoenolpyruvate carboxykinase. | Metabolic regulation by C1q/TNF-related protein-13 (CTRP13): activation OF AMP-activated protein kinase and suppression of fatty acid-induced JNK signaling.
Wei Z, Peterson JM, Wong GW., Free PMC Article | 07/2/2011 |